This cooperative venture will significantly reduce malpractice premiums for MiSEPS members by offering a 10% discount (averaging more than $1,300) to members for attending a qualifying cosponsored risk management event. CME credit available for some courses.
For more information on OMIC’s CV program contact Deena Mader at OMIC at 800-562-6642, ext. 628. www.omic.com
For Michigan state society membership, please contact Theresa Wiley, Associate Director for the Society at 313 823 1000 or email at twiley@miseps.org.
Visit the MiSEPS website for more info: www.MiSEPS.org.
Every year, ophthalmologists give hundreds of thousands of intravitreal and intraocular injections. The Center for Disease Control (CDC) has been very active in promoting safe injection practices. This CDC Position Paper provides the CDC’s “position” and “general messages” that all ophthalmologists should be aware of and implement in their practice.
The following is from the CDC website http://www.cdc.gov/injectionsafety/
Injected medicines are commonly used in healthcare settings for the prevention, diagnosis, and treatment of various illnesses. Unsafe injection practices put patients and healthcare providers at risk of infectious and non-infectious adverse events and have been associated with a wide variety of procedures and settings. This harm is preventable. Safe injection practices are part of Standard Precautions and are aimed at maintaining basic levels of patient safety and provider protections. As defined by the World Health Organization, a safe injection does not harm the recipient, does not expose the provider to any avoidable risks and does not result in waste that is dangerous for the community.
Visit the page on CDC’s role in safe injection practices.
UPDATE: A BIG thank you to the 200 attendees at OMIC’s risk management seminar Professional Liability Risks Associated with Premium IOL Implants yesterday! OMIC insureds earned an average of more than $1,100 in discounts for attending.
If you missed the event, there are still plenty of ways to earn your discount. See below for links to OMIC’s risk management seminar schedule and list of cooperative venture opportunities, and online and recorded courses.
We were delighted to see OMIC’s patient consent templates and other risk management resources referenced in the Ophthalmology Management article Avoiding 10 Common Malpractice Claims
See: http://www.ophthalmologymanagement.com/articleviewer.aspx?articleID=106880
http://www.ophthalmologymanagement.com
BLOG:
If you are attending the ASCRS-ASOA annual meeting at the McCormick Place, please plan to visit the OMIC Insurance Center at booth number 1423.
OMIC Risk Management Seminar:
Saturday, April 21, 2012 (Completed)
- Professional Liability Risks Associated with Premium IOL Implants- Effective Management of Presbyopia-Correcting Patients
- American Society of Cataract & Refractive Surgery 2012 (ASCRS)
- McCormick Place West Convention Ceter, Chicago, IL
- Time: 1:00-2:00 pm
- Register with ASCRS at (800) 748-5064 or go to www.ascrs.org
Continue reading…
It was 10 years ago this week that the FDA approved BOTOX for cosmetic uses. Now the most popular cosmetic procedure in the United States, BOTOX treatments were performed nearly 6 million times during 2011. See OMIC’s risk management recommendations, coverage requirements, and sample consent form, (and more) below.
History of BOTOX. Ophthalmologist Dr. Alan Scott of the Medical Research Institute in San Francisco and biochemist Dr. Ed Schantz of the University of Wisconsin were first to work on a standardized botulinum toxin preparation for therapeutic purposes in the 1960′s. Since then, the drug has been approved for 6 therapeutic indications.
Continue reading…
Ophthalmologists leave practices for many reasons. Whether discontinuing your practice due to an illness or disability, retirement, changes in employment status, or other personal or family reasons, you must take various actions to avoid allegations of patient abandonment.
OMIC has created a comprehensive guide to prevent liability and ensure continuity of care for your patients.
Continue reading…
In recent months OMIC has noted a surge in regulatory and HIPAA Privacy claims, especially involving malicious acts by disgruntled employees and unhappy patients.
In one case, a physician’s smart phone was compromised and more than 30 unauthorized breaches were recorded in one four hour period, requiring the practice to notify hundreds of patients of a potential release of their medical information. They also were required to report the incident to government authorities in order to comply with HIPAA requirements.
See here for HIPAA Security Rule.
Continue reading…
An alert was released this week by the American Academy of Ophthalmology (AAO) and the Food and Drug Administration (FDA) regarding the use of Brilliant Blue G for eye surgery. (See below) OMIC encourages policyholders who report cases to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program to also call OMIC’s Risk Management Hotline to report the incident and for advice on mitigating risks associated with the event.
Continue reading…
OMIC has issued more than $16 Million in premium credits for participation in our popular risk management courses since 2000. Upon completion of an OMIC online course, CD/DVD, or live seminar, OMIC physician insureds receive one risk management premium discount per premium year to be applied upon renewal. All programs qualify for a risk management discount equal to either 5% (standard) or 10% (approved cooperative venture event) of the insured’s premium.
Insureds who are members of a cooperative venture society earn the higher 10% discount (a credit worth up to $3,000) by participating in an approved OMIC risk management activity, which may be either a live seminar or an online or recorded course. Jointly-sponsored cooperative venture live events are indicated by CV Event below.
Continue reading…
The online review sites Healthgrades, Yelp, and Vitals have become a popular way for patients to research and choose an ophthalmologist. Like it or not, these (and other review) sites have virtually taken the place of the telephone book as the primary vehicle for people finding you. They also can pose a serious public relations risk for your practice since anyone can post practically anything they want – good or bad – about you in seconds, and often anonymously.
Continue reading…
When legal action is initiated against your practice alleging medical malpractice, plaintiff attorneys often carefully review your advertisements, radio and television commercials, web site and social media pages, marketing brochures, and patient education documents looking for inaccurate, unsubstantiated, or misleading information. Problematic statements in your advertisements, if relevant to the case, could sway potential jurors in favor of the plaintiff and require settlement of a claim even if your care was otherwise defensible.
Continue reading…
